🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 45674E208 (prev. 45674E109 )
- Market Cap
- Micro Cap
- IPO
- 7/30/2021 · $10.00/share
Business: IN8bio is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cell therapies for the treatment of cancer.
Company Contact
- CEO
- William Ho
- CFO
- Patrick McCall
- Headquarters
- 350 5th Avenue, Suite 5330, New York, NY 10118
- Phone
- 646-600-6438
- Investor Relations
- Patrick McCall · 646-600-6438 · info@IN8bio.com